yimitasvir
a hepatitis C virus nonstructural protein 5A (NS5A) inhibitor
Also Known As:
DAG-181; DAG181; yimitasvir phosphate
Networked: 2
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Chen, Rui:
1 article
(01/2020)
|
2. | Guan, Xiao-Duo:
1 article
(01/2020)
|
3. | Hu, Pei:
1 article
(01/2020)
|
4. | Luo, Lin:
1 article
(01/2020)
|
5. | Tang, Xian-Ge:
1 article
(01/2020)
|
6. | Wu, Dan:
1 article
(01/2020)
|
7. | Xie, Hong-Ming:
1 article
(01/2020)
|
8. | Zhang, Ying-Jun:
1 article
(01/2020)
|
9. | Chen, Guiling:
1 article
(07/2018)
|
10. | Chen, Hong:
1 article
(07/2018)
|
Related Diseases
Related Drugs and Biologics